294 related articles for article (PubMed ID: 23717002)
1. Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma.
Perrot CY; Javelaud D; Mauviel A
Ann Dermatol; 2013 May; 25(2):135-44. PubMed ID: 23717002
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta in cutaneous melanoma.
Javelaud D; Alexaki VI; Mauviel A
Pigment Cell Melanoma Res; 2008 Apr; 21(2):123-32. PubMed ID: 18426405
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta in cancer and metastasis.
Jakowlew SB
Cancer Metastasis Rev; 2006 Sep; 25(3):435-57. PubMed ID: 16951986
[TBL] [Abstract][Full Text] [Related]
4. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.
Pardali K; Moustakas A
Biochim Biophys Acta; 2007 Jan; 1775(1):21-62. PubMed ID: 16904831
[TBL] [Abstract][Full Text] [Related]
5. TGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth.
Marvin DL; Dijkstra J; Zulfiqar RM; Vermeulen M; Ten Dijke P; Ritsma L
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240029
[TBL] [Abstract][Full Text] [Related]
6. Overexpressed VEPH1 inhibits epithelial-mesenchymal transition, invasion, and migration of human cutaneous melanoma cells through inactivating the TGF-β signaling pathway.
Feng H; Jia XM; Gao NN; Tang H; Huang W; Ning N
Cell Cycle; 2019 Nov; 18(21):2860-2875. PubMed ID: 31599708
[TBL] [Abstract][Full Text] [Related]
7. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
8. Role of TGF-β in melanoma.
Busse A; Keilholz U
Curr Pharm Biotechnol; 2011 Dec; 12(12):2165-75. PubMed ID: 21619542
[TBL] [Abstract][Full Text] [Related]
9. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
Krasagakis K; Garbe C; Schrier PI; Orfanos CE
Anticancer Res; 1994; 14(6B):2565-71. PubMed ID: 7872682
[TBL] [Abstract][Full Text] [Related]
10. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-β.
Lv C; Dai H; Sun M; Zhao H; Wu K; Zhu J; Wang Y; Cao X; Xia Z; Xue C
Melanoma Res; 2017 Apr; 27(2):74-84. PubMed ID: 28079609
[TBL] [Abstract][Full Text] [Related]
12. EWI-2 negatively regulates TGF-β signaling leading to altered melanoma growth and metastasis.
Wang HX; Sharma C; Knoblich K; Granter SR; Hemler ME
Cell Res; 2015 Mar; 25(3):370-85. PubMed ID: 25656846
[TBL] [Abstract][Full Text] [Related]
13. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta: recent advances on its role in immune tolerance.
Mantel PY; Schmidt-Weber CB
Methods Mol Biol; 2011; 677():303-38. PubMed ID: 20941619
[TBL] [Abstract][Full Text] [Related]
15. Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis.
Fabregat I; Caballero-Díaz D
Front Oncol; 2018; 8():357. PubMed ID: 30250825
[TBL] [Abstract][Full Text] [Related]
16. TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression.
Daroqui MC; Vazquez P; Bal de Kier Joffé E; Bakin AV; Puricelli LI
Oncol Rep; 2012 Aug; 28(2):567-75. PubMed ID: 22614218
[TBL] [Abstract][Full Text] [Related]
17. Roles of TGF-β signaling pathway in tumor microenvirionment and cancer therapy.
Zhao H; Wei J; Sun J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107101. PubMed ID: 33099067
[TBL] [Abstract][Full Text] [Related]
18. TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis.
Hao Y; Baker D; Ten Dijke P
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195692
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells.
Ao M; Williams K; Bhowmick NA; Hayward SW
Cancer Res; 2006 Aug; 66(16):8007-16. PubMed ID: 16912176
[TBL] [Abstract][Full Text] [Related]
20. Distinct roles of transforming growth factor-β signaling and transforming growth factor-β receptor inhibitor SB431542 in the regulation of p21 expression.
Koo BH; Kim Y; Je Cho Y; Kim DS
Eur J Pharmacol; 2015 Oct; 764():413-423. PubMed ID: 26187313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
